Tirz

Tirzepatide 30 mg

Tirzepatide is a dual GIP/GLP-1 agonist — the active molecule in Mounjaro and Zepbound, and one of the most clinically validated weight-management compounds in the world.

What it does

• Dual mechanism: GIP and GLP-1 receptor activation
• Phase 3 trials averaged 20–22% body-weight reduction
• Anti-inflammatory effects beyond weight management
• Once-weekly dosing

How it's delivered

30 mg cartridge. Fits the reusable pen. Subcutaneous, once weekly.

Don't have a pen? Add a Disposable Pen — R125

Takes standard 3 ml cartridges. Or buy the reusable Starter Kit once.